For Biopharma

Education & events

News & Updates

Poster - 28 July 2024

Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials

Info Sheet - 16 July 2024

Global Trial Connect Brochure

Poster - 19 May 2024

Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists

Article - 17 May 2024

Leveraging global laboratory scale to deliver critical patient test results on time

Recent

Posters and publications

Poster - 20 October 2024

Receptor occupancy assay development challenges for rare targets of bispecific drugs

Poster - 20 October 2024

Per- and polyfluoroalkyl substances (PFAS): Validation of methodology for the determination of residues in fruit, fruit processed commodities and fish tissues

Poster - 20 October 2024

Validation of a quantitative PCR (qPCR) assay for the detection and quantification of replication competent lentivirus for patient monitoring in lentiviral vector-based cell therapy studies

Info Sheet - 1 August 2024

Nonclinical Solutions - Toxicology

Poster - 28 July 2024

Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials

Upcoming

Conferences & events

20-22 Nov 2024

EBF Open Symposium 2024

Visit conference site

19-23 Nov 2024

AMP Annual Meeting & Expo (Association for Molecular Pathology)

Visit conference site

17-20 Nov 2024

ACT (American Collge of Toxicology Annual Meeting)

Visit conference site

Recorded

Videos & Webinars

Webinar - 15 May 2024

Overcoming key challenges in global cell and gene therapy trials with Labcorp

Video - 25 April 2024

From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)

Video - 8 April 2024

Challenges and opportunities for bioanalytical support of new drug modalities

Trending

Scientific Topics

Info Sheet - 23 July 2024

Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability

Info Sheet - 23 July 2024

Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services

Article - 14 May 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Info Sheet - 2 May 2024

Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities

Article - 8 April 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

Article - 8 April 2024

Navigating complexities in ADC development with specialized global laboratory support and scientific expertise

Article - 7 December 2023

OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Article - 6 December 2023

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Article - 28 September 2023

Cell therapy for treatment of cancer

Managing Your Health

Diseases & Therapeutic Areas

Treatment Modalities & Methods

Scientific Lab Disciplines

Labs

Industries

Education & events

Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials

Global Trial Connect Brochure

Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists

Leveraging global laboratory scale to deliver critical patient test results on time

Posters and publications

Receptor occupancy assay development challenges for rare targets of bispecific drugs

Per- and polyfluoroalkyl substances (PFAS): Validation of methodology for the determination of residues in fruit, fruit processed commodities and fish tissues

Validation of a quantitative PCR (qPCR) assay for the detection and quantification of replication competent lentivirus for patient monitoring in lentiviral vector-based cell therapy studies

Nonclinical Solutions - Toxicology

Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials

Conferences & events

EBF Open Symposium 2024

AMP Annual Meeting & Expo (Association for Molecular Pathology)

ACT (American Collge of Toxicology Annual Meeting)

Videos & Webinars

Overcoming key challenges in global cell and gene therapy trials with Labcorp

From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)

Challenges and opportunities for bioanalytical support of new drug modalities

Scientific Topics

Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability

Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

Navigating complexities in ADC development with specialized global laboratory support and scientific expertise

OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Cell therapy for treatment of cancer